Difference between revisions of "Duvelisib (Copiktra)"
Jump to navigation
Jump to search
(Created page with "==Mechanism of action== PI3K-δ,γ inhibitor ==Preliminary data== # '''Abstract:''' Manish Patel, Brad S. Kahl, Steven M. Horwitz, Francine M. Foss, Yasuhiro Oki, Pierluigi P...") |
m |
||
| Line 4: | Line 4: | ||
==Preliminary data== | ==Preliminary data== | ||
# '''Abstract:''' Manish Patel, Brad S. Kahl, Steven M. Horwitz, Francine M. Foss, Yasuhiro Oki, Pierluigi Porcu, Jennifer Sweeney, Kerstin Allen, Kerrie Faia, Patricia Harris, Joi Dunbar, Howard M. Stern, Patrick Kelly, Susan O'Brien. Preliminary Safety and Efficacy Of IPI-145, a Potent Inhibitor Of Phosphoinositide-3-Kinase-δ,γ, In Patients With Chronic Lymphocytic Leukemia. Blood Nov 2013,122(21)677 [http://bloodjournal.hematologylibrary.org/content/122/21/677 link to original abstract] | # '''Abstract:''' Manish Patel, Brad S. Kahl, Steven M. Horwitz, Francine M. Foss, Yasuhiro Oki, Pierluigi Porcu, Jennifer Sweeney, Kerstin Allen, Kerrie Faia, Patricia Harris, Joi Dunbar, Howard M. Stern, Patrick Kelly, Susan O'Brien. Preliminary Safety and Efficacy Of IPI-145, a Potent Inhibitor Of Phosphoinositide-3-Kinase-δ,γ, In Patients With Chronic Lymphocytic Leukemia. Blood Nov 2013,122(21)677 [http://bloodjournal.hematologylibrary.org/content/122/21/677 link to original abstract] | ||
| + | |||
| + | [[Category:Drug index]] | ||
| + | [[Category:Chemotherapy]] | ||
| + | |||
| + | [[Category:Kinase inhibitors]] | ||
| + | [[Category:PI3K inhibitors]] | ||
[[Category:Investigational]] | [[Category:Investigational]] | ||
| − | |||
| − | |||
Revision as of 17:01, 14 November 2014
Mechanism of action
PI3K-δ,γ inhibitor
Preliminary data
- Abstract: Manish Patel, Brad S. Kahl, Steven M. Horwitz, Francine M. Foss, Yasuhiro Oki, Pierluigi Porcu, Jennifer Sweeney, Kerstin Allen, Kerrie Faia, Patricia Harris, Joi Dunbar, Howard M. Stern, Patrick Kelly, Susan O'Brien. Preliminary Safety and Efficacy Of IPI-145, a Potent Inhibitor Of Phosphoinositide-3-Kinase-δ,γ, In Patients With Chronic Lymphocytic Leukemia. Blood Nov 2013,122(21)677 link to original abstract